851 - 860 of 4301 Drugs
Bethkis (tobramycin inhalation solution)
Bethkis (tobramycin) is an aminoglycoside antibiotic used to treat cystic fibrosis patients with Pseudomonas aeruginosa. Bethkis is available in generic form.
Zynteglo (betibeglogene autotemcel suspension for iv infusion)
Zynteglo (betibeglogene autotemcel) is an autologous hematopoietic stem cell-based gene therapy indicated for the treatment of adult and pediatric patients with β-thalassemia who require regular red blood cell (RBC) transfusions.
Betimol (timolol ophthalmic solution)
Betimol (timolol) Ophthalmic Solution is a beta-blocker used to treat open-angle glaucoma and other causes of high pressure inside the eye.
Bevyxxa (betrixaban capsules)
Bevyxxa (betrixaban) capsules are a factor Xa (FXa) inhibitor indicated for the prophylaxis of venous thromboembolism (VTE) in adult patients hospitalized for an acute medical illness who are at risk for thromboembolic complications due to moderate or severe restricted mobility and other risk factors for VTE.
Mvasi (bevacizumab-awwb solution for intravenous infusion)
Mvasi (bevacizumab-awwb) Solution is a vascular endothelial growth factor-specific angiogenesis inhibitor indicated for the treatment of metastatic colorectal cancer, with intravenous 5-fluorouracil–based chemotherapy for first- or second-line treatment; for metastatic colorectal cancer, with fluoropyrimidine-irinotecan- or fluoropyrimidine-oxaliplatin-based chemotherapy for second-line treatment in patients who have progressed on a first-line bevacizumab product-containing regimen; for non-squamous non-small cell lung cancer, with carboplatin and paclitaxel for first line treatment of unresectable, locally advanced, recurrent or metastatic disease; for glioblastoma, as a single agent for adult patients with progressive disease following prior therapy; for metastatic renal cell carcinoma with interferon alfa; and for cervical cancer, in combination with paclitaxel and cisplatin or paclitaxel and topotecan in persistent, recurrent, or metastatic disease.
Zirabev (bevacizumab-bvzr injection)
Zirabev (bevacizumab-bvzr) is a vascular endothelial growth factor inhibitor indicated for the treatment of metastatic colorectal cancer, in combination with intravenous fluorouracil-based chemotherapy for first- or second-line treatment; and metastatic colorectal cancer, in combination with fluoropyrimidine¬irinotecan- or fluoropyrimidine-oxaliplatin-based chemotherapy for second-line treatment in patients who have progressed on a first-line bevacizumab product-containing regimen. Zirabev is biosimilar to Avastin (bevacizumab).
Bevespi Aerosphere (glycopyrrolate and formoterol fumarate inhalation aerosol)
Bevespi Aerosphere (glycopyrrolate and formoterol fumarate) inhalation aerosol is a combination of an anticholinergic and a long-acting beta2-adrenergic agonist (LABA) indicated for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD). Bevespi Aerosphere is not indicated for the relief of acute bronchospasm or for the treatment of asthma.
Brenzavvy (bexagliflozin tablets)
Brenzavvy (bexagliflozin) is a sodium-glucose co-transporter 2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.